Financial reports
10-K
2023 FY
Annual report
5 Feb 24
10-Q
2023 Q3
Quarterly report
2 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
21 Apr 23
10-K
2022 FY
Annual report
6 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
7 Feb 22
Current reports
8-K
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
2 Feb 24
8-K
Departure of Directors or Certain Officers
31 Jan 24
8-K
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
8 Jan 24
8-K
Regeneron Reports Third Quarter 2023 Financial and Operating Results
2 Nov 23
8-K
Results of Operations and Financial Condition
5 Oct 23
8-K/A
Submission of Matters to a Vote of Security Holders
8 Sep 23
8-K
Departure of Directors or Certain Officers
8 Sep 23
8-K
Regeneron Reports Second Quarter 2023 Financial and Operating Results
3 Aug 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Jun 23
8-K
Regeneron Reports First Quarter 2023 Financial and Operating Results
4 May 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
25 Sep 23
SC TO-T/A
Third party tender offer statement (amended)
12 Sep 23
SC TO-T/A
Third party tender offer statement (amended)
8 Sep 23
SC TO-T
Third party tender offer statement
25 Aug 23
SC TO-C
Information about tender offer
9 Aug 23
SC TO-T/A
Third party tender offer statement (amended)
31 May 22
SC TO-T/A
Third party tender offer statement (amended)
20 May 22
SC TO-T/A
Third party tender offer statement (amended)
11 May 22
SC TO-T
Third party tender offer statement
2 May 22
SC TO-C
Information about tender offer
19 Apr 22
Proxies
PX14A6G
Letter to shareholders
18 May 23
DEFA14A
Additional proxy soliciting materials
17 May 23
DEFA14A
Additional proxy soliciting materials
21 Apr 23
DEF 14A
Definitive proxy
21 Apr 23
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEFA14A
Additional proxy soliciting materials
21 Apr 22
DEF 14A
Definitive proxy
21 Apr 22
DEFA14A
Additional proxy soliciting materials
3 May 21
DEFA14A
Additional proxy soliciting materials
23 Apr 21
DEFA14A
Additional proxy soliciting materials
23 Apr 21
Other
UPLOAD
Letter from SEC
7 Nov 22
CORRESP
Correspondence with SEC
7 Oct 22
UPLOAD
Letter from SEC
21 Sep 22
UPLOAD
Letter from SEC
4 Jan 21
CORRESP
Correspondence with SEC
7 Dec 20
UPLOAD
Letter from SEC
20 Nov 20
CT ORDER
Confidential treatment order
15 Jul 20
CT ORDER
Confidential treatment order
8 Oct 19
CT ORDER
Confidential treatment order
14 May 19
CT ORDER
Confidential treatment order
9 May 19
Ownership
4
ARTHUR F RYAN
3 Apr 24
4
Marion McCourt
3 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
4
ANDREW J MURPHY
15 Mar 24
144
Notice of proposed sale of securities
14 Mar 24
4
ARTHUR F RYAN
5 Mar 24
4
Marion McCourt
5 Mar 24
144
Notice of proposed sale of securities
1 Mar 24
4
JOSEPH J LAROSA
28 Feb 24
4
GEORGE L SING
28 Feb 24